Skip to content

Clinical trials

Phase 3 Lewy Body Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lewy Body Disease Phase: Phase 3 Country / region: France Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ACADIA Pharmaceuticals Inc.1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease2
Lewy Body Disease2
Cognitive Dysfunction1
Corticobasal Degeneration1
Dementia1
Dementia, Vascular1
Hallucinations1
Neurodegenerative Diseases1
Psychotic Disorders1
Supranuclear Palsy, Progressive1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.